Waldencast plc (NASDAQ:WALD) Shares Sold by Bleakley Financial Group LLC

Bleakley Financial Group LLC cut its stake in Waldencast plc (NASDAQ:WALD) by 35.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 17,064 shares of the company’s stock after selling 9,233 shares during the quarter. Bleakley Financial Group LLC’s holdings in Waldencast were worth $69,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of WALD. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Waldencast by 293.9% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock valued at $25,000 after acquiring an additional 5,114 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Waldencast in the 4th quarter valued at about $42,000. Catalina Capital Group LLC increased its position in shares of Waldencast by 69.9% in the 4th quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock valued at $109,000 after purchasing an additional 11,154 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Waldencast by 52.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 43,250 shares of the company’s stock worth $157,000 after buying an additional 14,803 shares during the last quarter. Finally, McAdam LLC purchased a new stake in Waldencast during the third quarter worth approximately $62,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on WALD shares. DA Davidson upped their target price on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a research report on Wednesday, December 4th. Canaccord Genuity Group raised their target price on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, November 22nd. TD Cowen assumed coverage on Waldencast in a research note on Monday, December 16th. They issued a “hold” rating and a $4.30 price target on the stock. Telsey Advisory Group restated an “outperform” rating and set a $6.00 target price on shares of Waldencast in a research report on Monday, November 18th. Finally, Canaccord Genuity Group began coverage on Waldencast in a research report on Friday, October 25th. They set a “buy” rating and a $5.00 target price on the stock. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Waldencast has an average rating of “Moderate Buy” and an average price target of $5.76.

Waldencast Stock Performance

Shares of Waldencast stock opened at $3.37 on Thursday. Waldencast plc has a twelve month low of $2.40 and a twelve month high of $8.35. The company has a current ratio of 1.47, a quick ratio of 0.78 and a debt-to-equity ratio of 0.21. The business’s fifty day moving average price is $3.48 and its 200 day moving average price is $3.42.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.